drug
carbidopa
Marketedupdated 6mo agoby Bausch Health Americas Inc
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 24 investigational indications.
indications
investigational
Parkinson's Disease
all catalysts(100)
approval · 100
May 2, 1975
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Apr 29, 1977
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jan 25, 1978
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jan 26, 1978
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Mar 24, 1978
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jul 13, 1978
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Oct 22, 1979
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jan 29, 1980
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jan 29, 1980
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Feb 11, 1980
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Mar 12, 1980
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Mar 13, 1980
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Sep 9, 1980
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jan 12, 1981
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Aug 21, 1981
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Sep 2, 1981
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
May 4, 1983
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jun 9, 1983
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Mar 2, 1984
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
May 11, 1984
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Sep 13, 1984
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
May 6, 1985
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jul 12, 1985
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jul 30, 1985
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jan 17, 1986
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jan 17, 1986
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jan 17, 1986
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jan 17, 1986
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jan 17, 1986
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Feb 26, 1988
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Apr 21, 1988
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
May 30, 1991
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Dec 24, 1992
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Oct 7, 1993
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Jul 13, 1995
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
May 7, 1996
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
May 16, 1996
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
May 16, 1996
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Nov 7, 1997
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Nov 26, 1997
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Dec 4, 1997
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jun 10, 1998
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
May 10, 1999
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
May 10, 1999
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
May 10, 1999
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
May 10, 1999
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
May 10, 1999
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Aug 4, 1999
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Apr 4, 2000
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
May 2, 2000
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Jun 6, 2000
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jun 6, 2000
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Feb 1, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Feb 1, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Mar 16, 2001
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Mar 16, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Mar 16, 2001
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Mar 16, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Apr 11, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Apr 11, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Apr 11, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Apr 11, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Apr 11, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Apr 11, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Apr 11, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Apr 11, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Apr 11, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Oct 11, 2001
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Oct 11, 2001
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Sep 5, 2002
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Sep 5, 2002
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Jun 11, 2003
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Aug 2, 2007
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Aug 29, 2008
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Sep 26, 2008
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Dec 31, 2008
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Dec 31, 2008
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Feb 2, 2009
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Feb 2, 2009
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Oct 11, 2010
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Feb 1, 2011
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Feb 1, 2011
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Apr 5, 2013
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Jan 16, 2014
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Feb 14, 2014
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Jul 17, 2014
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Jul 17, 2014
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Jul 17, 2014
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jul 17, 2014
approval
$OGN13.81+0.22%
SINEMET CR (CARBIDOPA) — FDA approval
carbidopa
→
Jul 17, 2014
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jul 17, 2014
approval
$OGN13.81+0.22%
SINEMET (CARBIDOPA) — FDA approval
carbidopa
→
Jul 18, 2014
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Jul 18, 2014
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Jan 9, 2015
approval
$ABBV294.55-0.16%
DUOPA (CARBIDOPA) — FDA approval
carbidopa
→
May 22, 2015
approval
$ABBV294.55-0.16%
DUOPA (CARBIDOPA) — FDA approval
carbidopa
→
Dec 21, 2015
approval
$ABBV294.55-0.16%
DUOPA (CARBIDOPA) — FDA approval
carbidopa
→
Jan 26, 2016
approval
$ABBV294.55-0.16%
DUOPA (CARBIDOPA) — FDA approval
carbidopa
→
Jan 29, 2016
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Feb 18, 2016
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Feb 22, 2016
approval
$ORN12.42-2.13%
STALEVO 75 (CARBIDOPA) — FDA approval
carbidopa
→
Trials studying carbidopa
- phase2A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease
- phase3A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations
- phase1A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants
- —Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease
- phase2Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations
- phase1A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) Patients
- phase2Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa
- phase1A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that